Multifarious studies are rolling in for COVID-19 vaccines, but the imperative call for that stands by is its storage and transportation. Furthered, the unalterable factors for the storage of a robust vaccine depends on the temperature they need to be kept at for their vigor to remain intact.
Regardless of the technology, the temperature varies for divergent vaccines, because of the paths taken by companies in the grouping of the product.
With the arching vaccines, a hefty questioning hikes- whether India has the required cold chain.
What is a cold chain? Cool chain- pulls a finger on the mirage of actions, kit and kaboodle applied to uphold a product within an itemized low-temperature range from production to consumption.
Our veracious source innuendo: TheIndianEXPRESS.
Let’s have a look at some of the vaccines, that are in the processing:
Pfizer- biontech:
- Storage temperature required: -60 to -90 degrees Celsius.
- Does India have the required cold chain for this vaccine? No.
- What other things are stored at this temperature? Some viruses, drugs, chemicals, and tissue samples.
Moderna:
- Storage temperature required: -20 degrees Celsius. (but can be kept at regular refrigerated temperatures, for up to a month)
- Does India have the required cold chain for this vaccine? Yes, but it is limited.
- What other things are stored at this temperature? Polio vaccines.
Sputnik:
- Storage temperature required: -18 degrees Celsius. (in freeze- dried form)
- Does India have the required cold chain for this vaccine? Yes, but it is not clear how much additional capacity is required.
- What other things are stored at this temperature? Frozen meat for transportation.
Astrazeneca- oxford:
- Storage temperature required: +2 to +8 degrees Celsius.
- Does India have the required cold chain for this vaccine? Yes, but it is not clear how much additional capacity is required.
- What other things are stored at this temperature? Vaccines such as Hep-B, meningococcal and several other biologics.
Is it easy as pie to enroot an mRNA vaccine, such as Pfizer and Moderna, that can be stored at comparable warmer temperatures?
Many firms, namely: Gennova Biopharmaceuticals, German company CureVac, and Pfizer areplanning to modify the vaccines’ management that will allow the storage temperature to be +2 to +8 degrees Celsius, but lamentably that will take a long-serving.
